← Back to Search

Bronchoscopy

Robotic vs Electromagnetic Bronchoscopy for Lung Lesions (RELIANT Trial)

N/A

Waitlist Available

Led By Fabien Maldonado, MD, MSc

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of procedure, approximately 60 minutes

Awards & highlights

RELIANT Trial Summary

This trial compares two methods of bronchoscopy to diagnose lung lesions. It will help determine which is best.

Who is the study for?

The RELIANT Trial is for adults over 18 who are scheduled to undergo bronchoscopy to evaluate peripheral pulmonary lesions. It's not open to those already in a study requiring the use of either ILLUMISITE™ or Ion™ systems.Check my eligibility

What is being tested?

This trial compares two types of bronchoscopy: electromagnetic navigation (EMN) using the ILLUMISITE™ Platform and robotic-assisted bronchoscopy with the Ion™ Endoluminal System, focusing on their effectiveness in diagnosing lung abnormalities.See study design

What are the potential side effects?

Potential side effects may include discomfort at the procedure site, bleeding, infection risk from the instruments used, and possible complications related to lung tissue sampling.

RELIANT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of procedure, approximately 60 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of procedure, approximately 60 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of procedure, approximately 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnostic yield, defined as the proportion of procedures that results in acquisition of lesional tissue. Lesional tissue is defined by the presence of histopathological findings that readily explain the presence of a pulmonary lesion.

Secondary outcome measures

Duration of procedure

RELIANT Trial Design

2Treatment groups

Active Control

Group I: Ion™ Endoluminal System (SSCB bronchoscopy)Active Control1 Intervention

Participants in the Ion™ Endoluminal System arm will undergo a diagnostic bronchoscopy with the Ion™ Endoluminal System (SSCB) machine.

Group II: ILLUMISITE™ Platform (EMN bronchoscopy)Active Control1 Intervention

Participants in the ILLUMISITE™ Platform arm will undergo a diagnostic bronchoscopy with the ILLUMISITE™ Platform (EMN) machine.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

857 Previous Clinical Trials

671,780 Total Patients Enrolled

Fabien Maldonado, MD, MScPrincipal InvestigatorVanderbilt University Medical Center

Media Library

ILLUMISITE™ Platform (EMN bronchoscopy) (Bronchoscopy) Clinical Trial Eligibility Overview. Trial Name: NCT05705544 — N/A

Peripheral Pulmonary Lesions Research Study Groups: Ion™ Endoluminal System (SSCB bronchoscopy), ILLUMISITE™ Platform (EMN bronchoscopy)

Peripheral Pulmonary Lesions Clinical Trial 2023: ILLUMISITE™ Platform (EMN bronchoscopy) Highlights & Side Effects. Trial Name: NCT05705544 — N/A

ILLUMISITE™ Platform (EMN bronchoscopy) (Bronchoscopy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05705544 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available for participants in this experiment?

"The clinical trial described is no longer recruiting, as indicated by the data on clincialtrials.gov. The study was launched July 1st 2023 and last updated January 30th 2023; however, other trials are still actively accepting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)

Fabien Maldonado 2023. "Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05705544.